Delray Beach, FL, Sept. 21, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global IV equipment market will grow from USD 17.82 billion in 2026 to USD 23.92 billion by 2031, at a CAGR of 6.1% during the forecast period. Market growth is driven by increasing cases of chronic diseases, rising hospitalizations, and an aging population. Growing use of IV therapy across hospitals, clinics, and home care settings is increasing demand for safe and reliable devices. The introduction of needle-free connectors and smart infusion systems, together with advancements in healthcare infrastructure in developing countries, is contributing to market growth.

Get PDF Brochure - Market Data & Segmentation: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78345313

Key Market Highlights

  • Market size, 2026: USD 17.82 billion
  • Market forecast, 2031: USD 23.92 billion
  • Growth rate: CAGR of 6.1% (2026–2031)
  • Fastest-growing regional market: Asia Pacific
  • Fastest-growing product segment: Needle-free connectors & extension sets
  • Largest application segment: Medication administration
  • Largest end-user segment: Hospitals
  • Key players: Becton, Dickinson and Company (US), B. Braun SE (Germany), Baxter (US), Fresenius SE & Co. KGaA (Germany), ICU Medical, Inc. (US)

Why This Market Matters

The IV equipment market is expected to experience steady growth due to the increasing prevalence of chronic conditions, higher hospitalization rates, and a growing elderly population. Hospitals, clinics, and home care settings are increasingly using IV therapy, driving demand for reliable and safe devices. Ongoing technological innovations and improvements in healthcare infrastructure in developing regions are also contributing to market growth.

Market Overview

The IV equipment market functions within a highly interconnected ecosystem that includes product innovation, regulatory oversight, manufacturing, distribution, and end-user adoption across various care settings. Manufacturers include global device leaders, regional OEMs, and specialized small and medium-sized enterprises developing infusion pumps, IV sets, catheters, connectors, and safety-engineered disposables. Collaborations with academic institutions, clinical research organizations, and technology partners support advancements in material science, smart infusion algorithms, antimicrobial coatings, and interoperable system architectures. Regulatory agencies such as the FDA, EMA, and national health authorities oversee safety, sterility, performance standards, and post-market surveillance. End users include hospitals, ICUs, oncology centers, surgical departments, ambulatory infusion clinics, and home care providers.

Analyst Perspective

The IV equipment industry is moving toward safer, smarter, and more connected infusion solutions. Needle-free connectors, smart infusion systems, and connected devices are supporting safer IV therapy and improved usability across care settings. At the same time, the shift toward home and ambulatory infusion is increasing demand for portable, reliable, and user-friendly equipment. Companies that integrate safety features, connectivity, usability, and reliable device performance into their portfolios are expected to strengthen their competitive position.
Speak to Our Analyst - Get Custom Insights: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=78345313

Segment Analysis

By type, needle-free connectors & extension sets are expected to be the fastest-growing segment during the forecast period, driven by their safety, ease of use, and ability to reduce infection risks. These characteristics make them highly preferred in modern healthcare settings.

By end user, hospitals hold the largest market share due to a high number of inpatients requiring continuous IV therapy, advanced treatment facilities, and the growing adoption of modern IV devices.

By application, medication administration accounts for the largest share of the IV equipment market, as intravenous therapy allows for direct delivery of drugs into the bloodstream. This provides a faster therapeutic response, accurate dosing, and improved treatment effectiveness, particularly in intensive care units, oncology treatments, pain management, and severe infections.

Regional Analysis

Asia Pacific is the fastest-growing market for IV equipment. Growth is driven by rising healthcare expenditures, rapidly improving hospital infrastructure, and an increasing prevalence of chronic and acute diseases. Rapid urbanization, a growing elderly population, and greater adoption of advanced IV therapies, such as smart infusion systems and needle-free connectors, are also contributing to demand. Emerging economies such as China, India, and other Southeast Asian nations present significant growth opportunities due to enhanced access to healthcare and rising patient volumes.

Key Industry Trends

  • Increasing adoption of smart infusion systems
  • Growing use of needle-free connectors and safer IV technologies
  • Shift toward home and ambulatory infusion
  • Expansion of IV therapy across hospitals, clinics, and home care settings
  • Improving healthcare infrastructure and adoption of advanced IV devices in emerging markets

Competitive Landscape

The competitive landscape of the IV equipment market is led by established global companies including Becton, Dickinson and Company (US), B. Braun SE (Germany), Baxter (US), Fresenius SE & Co. KGaA (Germany), and ICU Medical, Inc. (US), along with other prominent players such as Terumo Corporation (Japan), Moog Inc. (US), Teleflex Incorporated (US), Cardinal Health (US), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China).

Related Reports
North America IV Equipment Market
Europe IV Equipment Market

CONTACT: About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/